Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Mouth Neoplasms × Everolimus × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Xerostomia 1 Recurrence 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Mouth Neoplasms 1 Meningioma 1 Head and Neck Neoplasms 1 Glioma 1 Brain Neoplasms 1

Interventions

Watchful Waiting 1 Proflavine 1 Optical Imaging 1 Everolimus 1 Biopsy 1 68Ga-FAPI 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03578432 2019-12-02

Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy

University of Arizona

Phase EARLY_PHASE1 Terminated

Head and Neck Neoplasms, Mouth Neoplasms, Xerostomia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡